Share on LinkedInShare on LinkedIn

ARTICLE · 31 MARCH 2020

Update — Antitrust And COVID-19

A&O Shearman
A&O Shearman
Contributor

A&O Shearman

Introducing A&O Shearman Unparalleled global depth for a changing world. Today more than ever,...

View firm profile
Explore more from A&O Shearman

The ongoing COVID-19 outbreak has, at least temporarily, reshaped the way that many companies do business.

United StatesAntitrust/Competition Law
  • US Agencies Encourage COVID-19-Related Collaboration
  • Practical Tips for Information Sharing & Document Creation
  • Possible Delays to US Merger Approvals

The ongoing COVID-19 outbreak has, at least temporarily, reshaped the way that many companies do business. Nevertheless, companies must continue to be vigilant about compliance with the antitrust laws and understand that the U.S. antitrust agencies will continue to scrutinize their behavior during this period (although EU competition authorities have taken an arguably more permissive approach, while maintaining that overt cartels at the expense of consumers will not be tolerated). In fact, on March 24, 2020, the Antitrust Division of the U.S. Department of Justice (DOJ) and U.S. Federal Trade Commission (FTC) issued a joint statement1 ("Joint Statement") to outline an expedited review process for certain collaborations and to remind the public that they are monitoring markets behavior during this global health

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from